Vonoprazan to prevent ulcers after variceal banding
Treatments studied
Part of Digestive system clinical trials.
This trial tests whether vonoprazan can reduce ulcers caused by a procedure that ties off enlarged veins in the esophagus (variceal band ligation). It is meant for people with liver cirrhosis who are scheduled to receive this treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old
- You have liver cirrhosis confirmed by a doctor or imaging
- You have enlarged veins in your esophagus that need to be tied off
- You can give permission in English or Urdu
- You are willing to take the study medicine and attend follow-up exams
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two medications, rabeprazole and vonoprazan, to see which one works better at preventing ulcers that can form after a procedure to treat varices (enlarged veins) in the esophagus. If you have cirrhosis and varices, this trial may help reduce pain and bleeding after your treatment.
This trial tests whether a heartburn medication (pantoprazole) helps patients with liver cirrhosis who have had a procedure to treat enlarged veins in the esophagus or stomach. It looks at how well the medicine works when given after this procedure to prevent complications.
This trial tests a medicine called vonoprazan for people whose acid reflux symptoms (like heartburn or coughing) don't get better with usual treatment. It aims to see if vonoprazan can help control those symptoms.
This trial tests vonaprazan (two doses) against esomeprazole to see which better heals moderate-to-severe reflux esophagitis (a damaged esophagus from acid reflux) in 8 weeks. You may qualify if you have had heartburn or regurgitation for at least a month and your doctor found grade B, C, or D damage on an endoscopy.
This study tests an investigational medicine given as an injection to help stop bleeding from stomach or duodenal ulcers. It may offer a new option for people who have active bleeding from these ulcers.
This trial tests two procedures to prevent re-bleeding from enlarged veins in the stomach (gastric varices) in people with liver cirrhosis. Both procedures aim to block off the abnormal veins to reduce the risk of another bleeding episode.
Hear when a new Cirrhoses, Liver trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.